Study of Abdominal Aortic Stent Grafts in the Treatment of Infrarenal Abdominal Aortic Aneurysms
NCT ID: NCT01783184
Last Updated: 2020-10-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
180 participants
OBSERVATIONAL
2012-06-30
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vascutek Anaconda™ Abdominal Aortic Aneurysm (AAA) Post-Market Surveillance Registry
NCT01744119
The Study of the Fenestrated Anaconda Device in the Treatment of Abdominal Aortic Aneurysms
NCT04592185
Post-Approval Study of the TREO Abdominal Stent-Graft System
NCT04697784
The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance Study
NCT01826344
Global Fenestrated Anaconda Clinical STudy
NCT03180996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Abdominal aortic stent grafts, inserted via the femoral artery, are used to treat infrarenal abdominal aortic aneurysms, removing the need for an invasive surgical procedure.
The aim of this observational study is to evaluate the long-term (5 year) benefits of the technique by documenting the overall mortality, complications (endoleak, migration), rate of surgical conversion, progression and rupture of the aneurysm in a cohort of patients who are representative of the treated population under real conditions of use.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vascutek Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Professor Dominique Midy
Role: PRINCIPAL_INVESTIGATOR
Groupe Hospitalier Pellegrin , Bordeaux, France
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinique Casamance
Aubagne, , France
Clinique Saint Etienne
Bayonne, , France
Clinique Aguilera
Biarritz, , France
Groupe Hospitalier Pellegrin
Bordeaux, , France
Centre Hospitalier Jacques Coeur
Bourges, , France
C.H. Prive Saint Martin
Caen, , France
Infirmerie Protestante
Caluire-et-Cuire, , France
Clinique Villette
Dunkirk, , France
Centre Hospitalier Universitaire - Hopital Michallon
Grenoble, , France
Clinique du Mail
La Rochelle, , France
Centre Hospitalier
La Rochelle, , France
Hopital Prive de l'Estuaire
Le Havre, , France
Clinique de L'Yvette
Longjumeau, , France
Clinique Bouchard
Marseille, , France
Hopital Fondation Saint Joseph
Marseille, , France
Hopital Prive Sainte Blandine
Metz, , France
Centre Hospitalier
Moulins, , France
Centre Hospitalalier Universitaire - Hopital Brabois
Nancy, , France
Polyclinique Francheville
Périgueux, , France
Centre Hospitalier
Périgueux, , France
Centre Hospitalier de Roanne
Roanne, , France
Clinique Saint Hilaire
Rouen, , France
Clinique Guillaume de Varye
Saint-Doulchard, , France
Clinique de l'Europe
Saint-Nazaire, , France
Centre Hospitalier Universitaire - Hopital Civil
Strasbourg, , France
Clinique Vauban
Valenciennes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EPI-ANA01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.